PHILADELPHIA, PA, UNITED STATES, July 28, 2025 /⁨EINPresswire.com⁩/ -- Virion Therapeutics, LLC, a clinical-stage biotechnology company, developing novel T cell-based immunotherapies that utilize first-in-class checkpoint modifiers, today, on World …